# Palmitic Acid and Human Microvascular Function

> **NCT06683534** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Medical College of Wisconsin** · enrollment: 40 (estimated)

## Conditions studied

- Microvascular Dysfunction
- Microvasculature
- Cardiovascular Diseases
- Cardiovascular Diseases (CVD)
- Microvascular Health
- Obesity and Overweight

## Interventions

- **DIETARY_SUPPLEMENT:** Quercetin (dietary supplement)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06683534
- **Lead sponsor:** Medical College of Wisconsin
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07
- **Primary completion:** 2030-12
- **Final completion:** 2030-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06683534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06683534, "Palmitic Acid and Human Microvascular Function". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06683534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*